Bausch + Lomb

Yahoo Finance • 7 months ago

Bausch + Lomb explores sale amid parent company's debt woes - report

Investing.com -- Bausch + Lomb (NYSE:BLCO) is exploring a potential sale as part of an effort to resolve issues related to its separation from parent company Bausch Health, which is burdened with significant debt, as per a Financial Times... Full story

Yahoo Finance • 8 months ago

Tech Stocks On Track For Best Session In 5 Months Ahead Of Fed Meeting; Small Caps Target Highest Close Since January 2022: What's Driving Markets Wednesday?

Tech Stocks On Track For Best Session In 5 Months Ahead Of Fed Meeting; Small Caps Target Highest Close Since January 2022: What's Driving Markets Wednesday? Tech stocks soared to their best session in five months on Wednesday, ahead of t... Full story

Yahoo Finance • last year

Is Bausch + Lomb Corporation (NYSE:BLCO) Trading At A 39% Discount?

Key Insights Using the 2 Stage Free Cash Flow to Equity, Bausch + Lomb fair value estimate is US$25.50 Current share price of US$15.64 suggests Bausch + Lomb is potentially 39% undervalued The US$20.58 analyst price target for BLCO is 19%... Full story

Yahoo Finance • 2 years ago

Bausch + Lomb Expands OTC Eye Care Portfolio, Acquires JNJ's Blink

Bausch + Lomb Corporation (NYSE: BLCO) has acquired Johnson & Johnson's (NYSE: JNJ) eye and contact lens drops brand Blink for $106.5 million to bolster its position in over-the-counter (OTC) consumer products for eye care. The deal marks... Full story

Yahoo Finance • 2 years ago

Eye-Care Company Bausch + Lomb Names Brent Saunders CEO

Eye-care company Bausch + Lomb Corp. named Brent Saunders as chief executive officer and chairman of its board. Mr. Saunders will succeed Joseph Papa, who had said last July that he would step down from his roles running the company and se... Full story